This report provides a comprehensive analysis of the global Lisdexamfetamine Dimesylate Generics market, examining its trajectory from 2025 through 2032. The study evaluates key segments, including capsules and chewable tablets, used primarily for treating ADHD and binge eating disorders. By analyzing regional trends across the Americas, APAC, and Europe, the research highlights growth drivers and competitive dynamics among major players like Teva and Sun Pharmaceutical. Ultimately, the report offers strategic insights into market opportunities, company portfolios, and evolving industry landscapes.

Executive Overview

The global Lisdexamfetamine Dimesylate Generics market is projected to experience significant growth from 2025 through 2032, expanding at a steady compound annual growth rate over the forecast period.

Lisdexamfetamine dimesylate generics are medications containing the same active ingredient, lisdexamfetamine, as the brand-name drug. These generic medications are utilized for the treatment of attention deficit hyperactivity disorder (ADHD) and moderate to severe binge eating disorder.

Regional Market Analysis

Global Outlook

The report provides a detailed analysis in US$ millions of the world Lisdexamfetamine Dimesylate Generics industry, reviewing total world sales in 2025 and providing a comprehensive analysis of projected sales for 2026 through 2032.

United States

The United States market for Lisdexamfetamine Dimesylate Generics is estimated to increase from 2025 through 2032, maintaining a consistent growth rate during this period.

China

The China market for Lisdexamfetamine Dimesylate Generics is estimated to increase from 2025 through 2032, maintaining a consistent growth rate during this period.

Europe

The Europe market for Lisdexamfetamine Dimesylate Generics is estimated to increase from 2025 through 2032, maintaining a consistent growth rate during this period.

Market Segmentation

By Type

• Capsules
• Chewable Tablets

By Application

• Attention Deficit Hyperactivity Disorder (ADHD)
• Bulimia
• Other

By Geography

• Americas: United States, Canada, Mexico, Brazil
• APAC: China, Japan, Korea, Southeast Asia, India, Australia
• Europe: Germany, France, UK, Italy, Russia
• Middle East & Africa: Egypt, South Africa, Israel, Turkey, GCC Countries

Competitive Landscape

Key Players

The following companies have been profiled based on inputs gathered from primary experts and analysis of company coverage, product portfolios, and market penetration:

• Hikma Pharmaceuticals
• Amneal Pharmaceuticals
• Sun Pharmaceutical Industries Ltd
• Teva Pharmaceutical
• Mallinckrodt PLC
• Mylan
• Sandoz
• Ascent Pharmaceuticals
• Alkem Laboratories
• Apotex
• Lannett
• Zhejiang Huahai Pharmaceutical

Market Share and Strategy

In terms of revenue, the global two largest companies occupied a significant portion of the market share in 2025. This report highlights key trends related to company formation, revenue, market share, latest developments, and M&A activity. Furthermore, it analyzes the strategies of leading global companies with a focus on:

• Lisdexamfetamine Dimesylate Generics portfolios and capabilities
• Market entry strategies
• Market positions
• Geographic footprints

Report Scope and Methodology

Produced by LP Information, Inc. (LPI), the “Lisdexamfetamine Dimesylate Generics Industry Forecast” utilizes a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs. The study offers a highly nuanced view of the current state and future trajectory of the market, evaluating key trends, drivers, and affecting factors. The report presents a comprehensive overview of market shares and growth opportunities by product type, application, key manufacturers, and key regions/countries.

Key Questions Addressed

• What is the 10-year outlook for the global Lisdexamfetamine Dimesylate Generics market?
• What factors are driving Lisdexamfetamine Dimesylate Generics market growth, globally and by region?
• Which technologies are poised for the fastest growth by market and region?
• How do Lisdexamfetamine Dimesylate Generics market opportunities vary by end market size?
• How does Lisdexamfetamine Dimesylate Generics break out by Type and by Application?

• 1 Scope of the Report

  • 1.1 Market Introduction

  • 1.2 Years Considered

  • 1.3 Research Objectives

  • 1.4 Market Research Methodology

  • 1.5 Research Process and Data Source

  • 1.6 Economic Indicators

  • 1.7 Currency Considered

  • 1.8 Market Estimation Caveats

• 2 Executive Summary

  • 2.1 World Market Overview

    • 2.1.1 Global Lisdexamfetamine Dimesylate Generics Annual Sales 2021-2032

    • 2.1.2 World Current & Future Analysis for Lisdexamfetamine Dimesylate Generics by Geographic Region, 2021, 2025 & 2032

    • 2.1.3 World Current & Future Analysis for Lisdexamfetamine Dimesylate Generics by Country/Region, 2021, 2025 & 2032

  • 2.2 Lisdexamfetamine Dimesylate Generics Segment by Type

    • 2.2.1 Capsules

    • 2.2.2 Chewable Tablets

    • 2.2.3 Lisdexamfetamine Dimesylate Generics Sales by Type

      • 2.2.3.1 Global Lisdexamfetamine Dimesylate Generics Sales Market Share by Type (2021-2026)
      • 2.2.3.2 Global Lisdexamfetamine Dimesylate Generics Revenue and Market Share by Type (2021-2026)
      • 2.2.3.3 Global Lisdexamfetamine Dimesylate Generics Sale Price by Type (2021-2026)

  • 2.3 Lisdexamfetamine Dimesylate Generics Segment by Application

    • 2.3.1 Attention Deficit Hyperactivity Disorder(ADHD)

    • 2.3.2 Bulimia

    • 2.3.3 Other

    • 2.3.4 Lisdexamfetamine Dimesylate Generics Sales by Application

      • 2.3.4.1 Global Lisdexamfetamine Dimesylate Generics Sale Market Share by Application (2021-2026)
      • 2.3.4.2 Global Lisdexamfetamine Dimesylate Generics Revenue and Market Share by Application (2021-2026)
      • 2.3.4.3 Global Lisdexamfetamine Dimesylate Generics Sale Price by Application (2021-2026)

• 3 Global by Company

  • 3.1 Global Lisdexamfetamine Dimesylate Generics Breakdown Data by Company

    • 3.1.1 Global Lisdexamfetamine Dimesylate Generics Annual Sales by Company (2021-2026)

    • 3.1.2 Global Lisdexamfetamine Dimesylate Generics Sales Market Share by Company (2021-2026)

  • 3.2 Global Lisdexamfetamine Dimesylate Generics Annual Revenue by Company (2021-2026)

    • 3.2.1 Global Lisdexamfetamine Dimesylate Generics Revenue by Company (2021-2026)

    • 3.2.2 Global Lisdexamfetamine Dimesylate Generics Revenue Market Share by Company (2021-2026)

  • 3.3 Global Lisdexamfetamine Dimesylate Generics Sale Price by Company

  • 3.4 Key Manufacturers Lisdexamfetamine Dimesylate Generics Producing Area Distribution, Sales Area, Product Type

    • 3.4.1 Key Manufacturers Lisdexamfetamine Dimesylate Generics Product Location Distribution

    • 3.4.2 Players Lisdexamfetamine Dimesylate Generics Products Offered

  • 3.5 Market Concentration Rate Analysis

    • 3.5.1 Competition Landscape Analysis

    • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)

  • 3.6 New Products and Potential Entrants

  • 3.7 Market M&A Activity & Strategy

• 4 World Historic Review for Lisdexamfetamine Dimesylate Generics by Geographic Region

  • 4.1 World Historic Lisdexamfetamine Dimesylate Generics Market Size by Geographic Region (2021-2026)

    • 4.1.1 Global Lisdexamfetamine Dimesylate Generics Annual Sales by Geographic Region (2021-2026)

    • 4.1.2 Global Lisdexamfetamine Dimesylate Generics Annual Revenue by Geographic Region (2021-2026)

  • 4.2 World Historic Lisdexamfetamine Dimesylate Generics Market Size by Country/Region (2021-2026)

    • 4.2.1 Global Lisdexamfetamine Dimesylate Generics Annual Sales by Country/Region (2021-2026)

    • 4.2.2 Global Lisdexamfetamine Dimesylate Generics Annual Revenue by Country/Region (2021-2026)

  • 4.3 Americas Lisdexamfetamine Dimesylate Generics Sales Growth

  • 4.4 APAC Lisdexamfetamine Dimesylate Generics Sales Growth

  • 4.5 Europe Lisdexamfetamine Dimesylate Generics Sales Growth

  • 4.6 Middle East & Africa Lisdexamfetamine Dimesylate Generics Sales Growth

• 5 Americas

  • 5.1 Americas Lisdexamfetamine Dimesylate Generics Sales by Country

    • 5.1.1 Americas Lisdexamfetamine Dimesylate Generics Sales by Country (2021-2026)

    • 5.1.2 Americas Lisdexamfetamine Dimesylate Generics Revenue by Country (2021-2026)

  • 5.2 Americas Lisdexamfetamine Dimesylate Generics Sales by Type (2021-2026)

  • 5.3 Americas Lisdexamfetamine Dimesylate Generics Sales by Application (2021-2026)

  • 5.4 United States

  • 5.5 Canada

  • 5.6 Mexico

  • 5.7 Brazil

• 6 APAC

  • 6.1 APAC Lisdexamfetamine Dimesylate Generics Sales by Region

    • 6.1.1 APAC Lisdexamfetamine Dimesylate Generics Sales by Region (2021-2026)

    • 6.1.2 APAC Lisdexamfetamine Dimesylate Generics Revenue by Region (2021-2026)

  • 6.2 APAC Lisdexamfetamine Dimesylate Generics Sales by Type (2021-2026)

  • 6.3 APAC Lisdexamfetamine Dimesylate Generics Sales by Application (2021-2026)

  • 6.4 China

  • 6.5 Japan

  • 6.6 South Korea

  • 6.7 Southeast Asia

  • 6.8 India

  • 6.9 Australia

  • 6.10 China Taiwan

• 7 Europe

  • 7.1 Europe Lisdexamfetamine Dimesylate Generics by Country

    • 7.1.1 Europe Lisdexamfetamine Dimesylate Generics Sales by Country (2021-2026)

    • 7.1.2 Europe Lisdexamfetamine Dimesylate Generics Revenue by Country (2021-2026)

  • 7.2 Europe Lisdexamfetamine Dimesylate Generics Sales by Type (2021-2026)

  • 7.3 Europe Lisdexamfetamine Dimesylate Generics Sales by Application (2021-2026)

  • 7.4 Germany

  • 7.5 France

  • 7.6 UK

  • 7.7 Italy

  • 7.8 Russia

• 8 Middle East & Africa

  • 8.1 Middle East & Africa Lisdexamfetamine Dimesylate Generics by Country

    • 8.1.1 Middle East & Africa Lisdexamfetamine Dimesylate Generics Sales by Country (2021-2026)

    • 8.1.2 Middle East & Africa Lisdexamfetamine Dimesylate Generics Revenue by Country (2021-2026)

  • 8.2 Middle East & Africa Lisdexamfetamine Dimesylate Generics Sales by Type (2021-2026)

  • 8.3 Middle East & Africa Lisdexamfetamine Dimesylate Generics Sales by Application (2021-2026)

  • 8.4 Egypt

  • 8.5 South Africa

  • 8.6 Israel

  • 8.7 Turkey

  • 8.8 GCC Countries

• 9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers & Growth Opportunities

  • 9.2 Market Challenges & Risks

  • 9.3 Industry Trends

• 10 Manufacturing Cost Structure Analysis

  • 10.1 Raw Material and Suppliers

  • 10.2 Manufacturing Cost Structure Analysis of Lisdexamfetamine Dimesylate Generics

  • 10.3 Manufacturing Process Analysis of Lisdexamfetamine Dimesylate Generics

  • 10.4 Industry Chain Structure of Lisdexamfetamine Dimesylate Generics

• 11 Marketing, Distributors and Customer

  • 11.1 Sales Channel

    • 11.1.1 Direct Channels

    • 11.1.2 Indirect Channels

  • 11.2 Lisdexamfetamine Dimesylate Generics Distributors

  • 11.3 Lisdexamfetamine Dimesylate Generics Customer

• 12 World Forecast Review for Lisdexamfetamine Dimesylate Generics by Geographic Region

  • 12.1 Global Lisdexamfetamine Dimesylate Generics Market Size Forecast by Region

    • 12.1.1 Global Lisdexamfetamine Dimesylate Generics Forecast by Region (2027-2032)

    • 12.1.2 Global Lisdexamfetamine Dimesylate Generics Annual Revenue Forecast by Region (2027-2032)

  • 12.2 Americas Forecast by Country (2027-2032)

  • 12.3 APAC Forecast by Region (2027-2032)

  • 12.4 Europe Forecast by Country (2027-2032)

  • 12.5 Middle East & Africa Forecast by Country (2027-2032)

  • 12.6 Global Lisdexamfetamine Dimesylate Generics Forecast by Type (2027-2032)

  • 12.7 Global Lisdexamfetamine Dimesylate Generics Forecast by Application (2027-2032)

• 13 Key Players Analysis

  • 13.1 Hikma Pharmaceuticals

    • 13.1.1 Hikma Pharmaceuticals Company Information

    • 13.1.2 Hikma Pharmaceuticals Lisdexamfetamine Dimesylate Generics Product Portfolios and Specifications

    • 13.1.3 Hikma Pharmaceuticals Lisdexamfetamine Dimesylate Generics Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.1.4 Hikma Pharmaceuticals Main Business Overview

    • 13.1.5 Hikma Pharmaceuticals Latest Developments

  • 13.2 Amneal Pharmaceuticals

    • 13.2.1 Amneal Pharmaceuticals Company Information

    • 13.2.2 Amneal Pharmaceuticals Lisdexamfetamine Dimesylate Generics Product Portfolios and Specifications

    • 13.2.3 Amneal Pharmaceuticals Lisdexamfetamine Dimesylate Generics Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.2.4 Amneal Pharmaceuticals Main Business Overview

    • 13.2.5 Amneal Pharmaceuticals Latest Developments

  • 13.3 Sun Pharmaceutical Industries Ltd

    • 13.3.1 Sun Pharmaceutical Industries Ltd Company Information

    • 13.3.2 Sun Pharmaceutical Industries Ltd Lisdexamfetamine Dimesylate Generics Product Portfolios and Specifications

    • 13.3.3 Sun Pharmaceutical Industries Ltd Lisdexamfetamine Dimesylate Generics Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.3.4 Sun Pharmaceutical Industries Ltd Main Business Overview

    • 13.3.5 Sun Pharmaceutical Industries Ltd Latest Developments

  • 13.4 Teva Pharmaceutical

    • 13.4.1 Teva Pharmaceutical Company Information

    • 13.4.2 Teva Pharmaceutical Lisdexamfetamine Dimesylate Generics Product Portfolios and Specifications

    • 13.4.3 Teva Pharmaceutical Lisdexamfetamine Dimesylate Generics Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.4.4 Teva Pharmaceutical Main Business Overview

    • 13.4.5 Teva Pharmaceutical Latest Developments

  • 13.5 Mallinckrodt PLC

    • 13.5.1 Mallinckrodt PLC Company Information

    • 13.5.2 Mallinckrodt PLC Lisdexamfetamine Dimesylate Generics Product Portfolios and Specifications

    • 13.5.3 Mallinckrodt PLC Lisdexamfetamine Dimesylate Generics Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.5.4 Mallinckrodt PLC Main Business Overview

    • 13.5.5 Mallinckrodt PLC Latest Developments

  • 13.6 Mylan

    • 13.6.1 Mylan Company Information

    • 13.6.2 Mylan Lisdexamfetamine Dimesylate Generics Product Portfolios and Specifications

    • 13.6.3 Mylan Lisdexamfetamine Dimesylate Generics Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.6.4 Mylan Main Business Overview

    • 13.6.5 Mylan Latest Developments

  • 13.7 Sandoz

    • 13.7.1 Sandoz Company Information

    • 13.7.2 Sandoz Lisdexamfetamine Dimesylate Generics Product Portfolios and Specifications

    • 13.7.3 Sandoz Lisdexamfetamine Dimesylate Generics Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.7.4 Sandoz Main Business Overview

    • 13.7.5 Sandoz Latest Developments

  • 13.8 Ascent Pharmaceuticals

    • 13.8.1 Ascent Pharmaceuticals Company Information

    • 13.8.2 Ascent Pharmaceuticals Lisdexamfetamine Dimesylate Generics Product Portfolios and Specifications

    • 13.8.3 Ascent Pharmaceuticals Lisdexamfetamine Dimesylate Generics Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.8.4 Ascent Pharmaceuticals Main Business Overview

    • 13.8.5 Ascent Pharmaceuticals Latest Developments

  • 13.9 Alkem Laboratories

    • 13.9.1 Alkem Laboratories Company Information

    • 13.9.2 Alkem Laboratories Lisdexamfetamine Dimesylate Generics Product Portfolios and Specifications

    • 13.9.3 Alkem Laboratories Lisdexamfetamine Dimesylate Generics Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.9.4 Alkem Laboratories Main Business Overview

    • 13.9.5 Alkem Laboratories Latest Developments

  • 13.10 Apotex

    • 13.10.1 Apotex Company Information

    • 13.10.2 Apotex Lisdexamfetamine Dimesylate Generics Product Portfolios and Specifications

    • 13.10.3 Apotex Lisdexamfetamine Dimesylate Generics Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.10.4 Apotex Main Business Overview

    • 13.10.5 Apotex Latest Developments

  • 13.11 Lannett

    • 13.11.1 Lannett Company Information

    • 13.11.2 Lannett Lisdexamfetamine Dimesylate Generics Product Portfolios and Specifications

    • 13.11.3 Lannett Lisdexamfetamine Dimesylate Generics Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.11.4 Lannett Main Business Overview

    • 13.11.5 Lannett Latest Developments

  • 13.12 Zhejiang Huahai Pharmaceutical

    • 13.12.1 Zhejiang Huahai Pharmaceutical Company Information

    • 13.12.2 Zhejiang Huahai Pharmaceutical Lisdexamfetamine Dimesylate Generics Product Portfolios and Specifications

    • 13.12.3 Zhejiang Huahai Pharmaceutical Lisdexamfetamine Dimesylate Generics Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.12.4 Zhejiang Huahai Pharmaceutical Main Business Overview

    • 13.12.5 Zhejiang Huahai Pharmaceutical Latest Developments

• 14 Research Findings and Conclusion